17th World Congress on Heart Disease (WCHD) 2012

  • Conference Call
  • On behalf of the Organizing Committee, it is my great pleasure to invite you to participate in the International Academy of Cardiology, 17th World Congress on heart disease, Annual Scientific Sessions 2012, Toronto, ON, Canada, July 27-30, 2012.

    The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery.

    Many distinguished cardiologists and scientists have agreed to join the faculty participating in this Congress. Papers will be presented in the form of plenary sessions, symposia and posters, and will include superb scientific material originating from numerous laboratories around the globe, assuring that the meeting will be a major scientific event.

    Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials.

    We hope that you will participate in this Congress and submit for presentation your most recent scientific work in the rapidly evolving field of cardiovascular disease. Your interaction with your colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding.

    Conference Topics

    • ACE inhibitors and Angiotensin-ll receptor blockers
    • Acute myocardial infarction: thrombolysis and reperfusion
    • Angioplasty or surgery for multivessel coronary artery disease
    • Angioplasty therapy for acute MI
    • Antithrombotic and antiplatelet adjunctive therapy for PTCA
    • Arrhythmias and antiarrhythmic drug therapy - basic and clinical
    • Beta-blockers and beta-adrenergic receptors in heart failure
    • Biochemical markers of acute ischemia
    • Blockade of tissue proliferation after coronary interventions
    • Calcium channel blockers and promoters in heart failure
    • Cardiac transplantation
    • Computers in cardiology
    • Contrast echocardiography
    • Diabetes mellitus, obesity, insulin and atherosclerosis
    • Digoxin and other new inotropic agents in heart failure
    • Dilated cardiomyopathy: various etiologies
    • Echocardiography: TEE and 3-D
    • Electrophysiologic techniques of mapping and radiofrequency ablation
    • Exercise physiology in heart failure
    • Genetic determinants of coronary heart disease/cardiomyopathies
    • Gene transfer and therapy
    • Hormone therapy in postmenopausal women
    • Hypertension, basic and clinical
    • Internal defibrillation/implantable antiarrhythmic devices/pacing
    • Left ventricular hypertrophy and hypertrophic cardiomyopathy
    • Left ventricular remodeling after MI
    • Mechanical support left ventricular assist devices
    • Miscellaneous
    • Modification of lipoproteins and coronary disease
    • Molecular cardiology, Basic research
    • Myocardial stunning, Hibernation and preconditioning
    • Myocyte and receptor abnormalities in heart failure
    • Natriuretic peptides, endothelin: role in heart failure
    • Neurohumoral, immunologic and cytokine aspects of heart failure
    • New approaches to surgical revascularization: minimally invasive surgery, TMLR
    • Nitrates, beta blockers, calcium entry blockers and ACE inhibition drugs for ischemic heart disease
    • Nitric oxide and nitric oxide synthase in heart failure
    • Nuclear Cardiology
    • Organic nitrates-their role in heart failure management
    • Other diagnostic methods: Percutaneous coronary angioscopy / intravascular ultrasound imaging /intracoronary flow, doppler measurements
    • Pediatric cardiology and cardiac surgery/congenital heart disease
    • PET/MRI/CT
    • Pharmacologic modulation of vascular-endothelial function
    • Pharmacologic stress testing - Echocardiography
    • Plaque and acute coronary syndromes
    • Practice guidelines, cost containment
    • Predictors and markers of heart failure outcome
    • Primary prevention of coronary artery disease in the healthy adult and children
    • Pulmonary circulation aspects, pulmonary hypertension
    • Renal aspects - diuretics
    • Restenosis - use of ionizing radiation
    • Role of the pericardium - basic and clinical
    • Secondary prevention, prognosis, risk stratification, cardiac rehab
    • Stents: new devices/optimal application/multiple stents
    • Sudden death
    • Surgery for LV dysfunction
    • Valvular heart disease/Heart valve surgery-adult
    • Vascular biology, Basic research
    starting: ending: 30.07.2012 Location: , Category:

    Timeline

    Conference START 30.07.2012 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address The Fairmont Royal York, 199 Queen Street West Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.